Fight Illicit Pill Presses Act
Summary
The Fight Illicit Pill Presses Act (S. 2870) is an early-stage, non-funding bill that expands DEA recordkeeping rules to makers of pill press equipment. With no procurement, subsidy, or prohibition, market impact is negligible. Illinois Tool Works ($ITW), the only publicly traded company plausibly in this manufacturing niche, faces no material financial effect.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.S. 2870 is a procedural, non-funding bill at the earliest legislative stage — referred to committee with no action since September 2025.
- 2.No pure-play public company makes pill presses; the only diversified industrial name ($ITW) sees immaterial compliance costs.
- 3.Passage probability is low in current Congress; even if enacted, impact on public equities is effectively zero.
Market Implications
This bill is noise for equity markets. $ITW at $258.92 is trading based on broader industrial demand, interest rates, and its own organic growth — not DEA pill press serialization rules. There are no actionable trades or positioning changes warranted by S. 2870. Retail investors should ignore this legislation entirely.
Full Analysis
The Fight Illicit Pill Presses Act was introduced on September 18, 2025 by Senator Cornyn (R-TX) and 13 cosponsors. It is currently in the earliest legislative stage — referred to the Senate Judiciary Committee, with no hearings or markup. A companion bill (H.R. 5880) exists in the House, but both are essentially fledgling proposals with zero legislative velocity since introduction.
The bill does not authorize or appropriate any federal funds. It amends the Controlled Substances Act to require that anyone manufacturing, distributing, or selling tableting machines, encapsulating machines, or their critical components (upper punches, lower punches, dies) maintain records and identify each machine by serial number. This is purely a regulatory paperwork expansion — no grants, no tax credits, no direct procurement.
Structural winners and losers: There are no pure-play public companies that derive primary revenue from pill press manufacturing. The diversified industrial manufacturer most likely to touch this equipment is Illinois Tool Works ($ITW), which operates dozens of specialty industrial units. However, pill press machinery is a tiny fraction of ITW's business. No other publicly traded US company is directly affected. Increased DEA compliance costs will be negligible even for small private manufacturers.
Market data shows $ITW at $258.92 as of April 30, 2026, down 3.85% over the past 7 days. However, this decline is attributable to broader market conditions — the stock is within its 52-week range of $236.68—$303.16. There is no credible basis to link ITW's recent price movement to S. 2870.
Legislative timeline: The bill has been dormant for over 7 months. No committee action, no amendments, no markups. Given the early stage, lack of funding, and the 119th Congress now in its second session, passage probability is low unless the bill gains significant sponsorship momentum. Even if passed eventually, the financial impact on public markets would remain negligible.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
No confirming evidence found yet from contracts, insider trades, or congressional activity
What the bill does
Expansion of DEA recordkeeping and serialization requirements under the Controlled Substances Act to manufacturers, distributors, and sellers of tableting machines, encapsulating machines, and critical parts (punches, dies).
Who must act
Any person who manufactures, distributes, delivers, sells, imports, or exports a tableting machine, encapsulating machine, or critical part in the United States.
What happens
Imposes incremental compliance costs (serial number tracking, recordkeeping, regulatory paperwork) for producers of industrial pill press equipment. No prohibition, no licensing cap, no tax, and no procurement mandate is created.
Stock impact
ITW manufactures a broad range of industrial equipment and specialty products. Pill press machinery represents a negligible fraction of ITW's ~$16B annual revenue across 50+ decentralized business units. Compliance cost increases are immaterial to overall earnings.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Enhancing Program Integrity and Integrity and Interagency Coordination in the Administration of the H-1B Nonimmigrant Visa Program
This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.
Restoring Reciprocity in Government Procurement
This Presidential Memorandum directs the Office of Management and Budget, the U.S. Trade Representative, and other federal agencies to identify and remove Canadian-origin items from federal civil procurement where possible, citing Canada's 'Buy Canadian' policies as discriminatory. It also requires agencies to be notified of domestic alternatives and mandates ongoing monitoring of Canada's procurement practices, with provisions for restoring access if Canada changes its policies.
Excluding Certain Canadian Alcoholic Beverages from Importation into the United States in Response to Continued Discrimination Against the Commerce of the United States with Respect to Alcoholic Beverages
President Trump, invoking Section 338 of the Tariff Act of 1930, orders an import ban on certain Canadian alcoholic beverages effective September 29, 2026, escalating previous 50% ad valorem duties. This action targets Canadian discrimination against U.S. alcoholic beverages, citing Canada's broken commitments and additional retaliation. The ban replaces the tariff for specified products with a complete exclusion from entry into the United States.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →